Is early CLL treatment worth the cost? new study aims to find out
NCT ID NCT05371808
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study looks at the costs and quality of life for people with high-risk chronic lymphocytic leukemia (CLL) who either start treatment right away or wait. Researchers will track medical visits, tests, and hospital stays over 10 years. The goal is to see which approach gives the best value for the healthcare system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors and health systems decide the most cost-effective timing for treating high-risk CLL, potentially saving money while maintaining patient outcomes.
- What could go wrong
- This is an economic analysis, not a treatment trial, so it won't directly improve health. Results depend on assumptions and may not apply outside Canada.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BCCA - Vancouver
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
-
CancerCare Manitoba
RECRUITINGWinnipeg, Manitoba, R3E 0V9, Canada
-
Lakeridge Health Oshawa
NOT_YET_RECRUITINGOshawa, Ontario, L1G 2B9, Canada
-
Ottawa Hospital Research Institute
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
Regional Health Authority B, Zone 2
RECRUITINGSaint John, New Brunswick, E2L 4L2, Canada
-
The Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can a Three-Drug combo outsmart High-Risk CLL?
- Can a gentler dose of zanubrutinib keep CLL at bay in the very elderly?
- Can a Two-Drug combo wipe out hidden leukemia cells?
- Can a Chemo-Free pill combo outsmart leukemia at first diagnosis?